Encompass Health Corporation (EHC) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Encompass Health Corporation  (NYSE: EHC)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Encompass Health's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Encompass Health's ROI in the third quarter of 2026?
Encompass Health Corporation achieved a return on average invested assets (ROI) of 10.73 % in its third quarter of 2026, this is above EHC's average return on investment of 9.49%.
Encompass Health Corporations investments during the 12 months ending in the third quarter of 2026 are valued at $7 billion

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 24 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 578 to 624.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 28.28 % 21.76 % 12.33 % 12.12 % 11.36 %
Y / Y Net Income Change TTM 12.27 % 20.3 % 59.67 % 143.85 % 389.6 %
Investment (TTM) in Millions 8,712 8,693 6,463 6,280 6,130
Return On Investment (TTM) 10.73 % 12.09 % 13.07 % 12.56 % 12.26 %
EHC's Overall Ranking # 624 # 578 # 478 # 449 #
Seq. Investment Change TTM 9.37 % 11.07 % 2.69 % 2.83 % 3.8 %
Seq. Net Income Change TTM -2.96 % 2.78 % 6.81 % 5.4 % 3.97 %
Net Income (TTM) in Millions 809 833 811 759 720

EHC Company Profile >> Back to EHC Roi Comparisons >> See Annual EHC Return On Investment



Return On Investment EHC's Ranking
Within: No.
Industry # 4
Sector # 25
Overall # 624

Return On Investment Statistics
High Average Low
20.01 %
9.49 %
6.13 %
(Dec 31 2013)   (Sep 30 2020)







Financial Statements
Encompass Health's III. Quarter Investments $ 8,712 Millions EHC's Balance sheet
Encompass Health's III. Quarter Income $ 150 Millions Quarterly EHC's Income Statement
EHC's Income by Division See EHC's Income by Division


EHC Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 5,930 5,399 5,163 4,778 5,816
Y / Y Investment Growth 9.84 % 4.57 % 8.06 % -17.85 % 6.39 %
Net Income in Millions 759 597 463 366 517
Y / Y Net Income Growth 27.24 % 28.86 % 26.54 % -29.25 % 40.24 %
Annual Return On Investment 12.8 % 11.05 % 8.97 % 7.66 % 8.89 %


Annual Roi Comment
In the fiscal year 2025 ROI improved to 12.8 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EHC's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EHC's Competitors
Subscribers only: Roi for Encompass Health's Suppliers
Subscribers only: Return On Investment for EHC's Customers

Other Ratios
EHC's Roa EHC's Inventory Turnover Ratio EHC's Growth Rates EHC's Dividend Statistics
EHC's Profitability Ratios EHC's Asset Turnover Ratio EHC's Dividend Growth
EHC's Roe EHC's Valuation Ratios EHC's Financial Strength Ratios EHC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Acadia Pharmaceuticals Inc   26.89 %
Protalix Biotherapeutics inc   26.06 %
Standard Biotools Inc   23.91 %
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %

Date modified: 2026-11-04T16:48:36+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.